Ursula von der Leyen speaks at the plenary session of the European Parliament, July 18, 2024 (Philipp von Ditfurth/picture-alliance/dpa/AP Images)
July 19, 2024 11:25 AM EDT
Pharma

Eu­ro­pean Com­mis­sion pres­i­dent’s sec­ond-term pledge: sim­pler reg­u­la­tions, bet­ter fund­ing and tack­ling short­ages

Ayisha Sharma

News Reporter

Ur­su­la von der Leyen won a sec­ond term as pres­i­dent of the Eu­ro­pean Com­mis­sion on Thurs­day, with 401 votes in fa­vor …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times